LYCOS RETRIEVER 
Patent: Us Patent
built 664 days ago
In the non-final Action Closing Prosecution the patent examiner allowed the specific formulation claim for TACLONEX ointment, but rejected the remaining pending claims in the reexamination of LEO's 013 Patent. LEO intends to vigorously defend the 013 Patent and will file a response with the USPTO.
Source:
PartsSource, the nation's leading supplier of replacement medical parts for hospital equipment has been awarded an exclusive US Patent for its ground-breaking PartsFinder(TM) application. The Patent gives PartsSource exclusive US rights for the use of its supplier selection model critical designed to quickly identify preferred vendors in a specific supply chain.
Source:
MORE ABOUT
Us Patent